Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephropathy; Toxic, Drugs”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Large-scale testing (Phase 3)UnknownNCT01501968
What this trial is testing

Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity

Who this might be right for
Drug Safety
Mahidol University 54
Not applicableStudy completedNCT00805571
What this trial is testing

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Dysfunction
Northwell Health 120
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Not applicableEnded earlyNCT00213642
What this trial is testing

Tc-99m Renography and Cisplatin-induced Nephrotoxicity

Who this might be right for
CancerDrug ToxicityKidney Failure
University Hospital, Rouen 20
Post-approval studies (Phase 4)Study completedNCT06139952
What this trial is testing

Ameliorating Contrast Induced Nephropathy After Coronary Angiography

Who this might be right for
Coronary Artery DiseaseNephropathy; Toxic, Drugs
Ain Shams University 120
Not applicableStudy completedNCT03527160
What this trial is testing

Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications

Who this might be right for
Acute Kidney InjuryNephrotoxicity
Children's Hospital Medical Center, Cincinnati 134
Not applicableStudy completedNCT05533606
What this trial is testing

Risk Factors and Machine Learning Model for Beta-Lactam Drugs Related Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryBeta-Lactam Antibiotic Toxicity (Diagnosis)
Qianfoshan Hospital 19,000
Not applicableWithdrawnNCT00834496
What this trial is testing

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Who this might be right for
Side Effects of Calcineurin InhibitorsRenal ToxicityHepatic Fibrosis on Biopsy+2 more
Thomas Jefferson University
Not applicableLooking for participantsNCT04659343
What this trial is testing

TDM for Optimized Outcome in Patients With mRCC.

Who this might be right for
Kidney CancerRenal Cell Carcinoma MetastaticDrug Toxicity+2 more
Niels Fristrup 200
Not applicableStudy completedNCT06122311
What this trial is testing

Drug Nephrotoxicity Amelioration by N-acetylcysteine

Who this might be right for
Drug-Induced Nephropathy
Helwan University 100
Not applicableUnknownNCT01624324
What this trial is testing

Aminoglycoside Plasma Level Measurement in Neonates With Infection

Who this might be right for
NephrotoxicityOtotoxicity
Indonesia University 25
Not applicableUnknownNCT06019520
What this trial is testing

Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity

Who this might be right for
Drug Toxicity
Foundation University Islamabad 70
Not applicableUnknownNCT01936376
What this trial is testing

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

Who this might be right for
Head and Neck Cancer
Foundation for the National Institutes of Health 150
Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)UnknownNCT04817904
What this trial is testing

Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity

Who this might be right for
Cisplatin Adverse Reaction
Cairo University 65
Not applicableUnknownNCT01543620
What this trial is testing

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Foundation for the National Institutes of Health 150
Testing effectiveness (Phase 2)Looking for participantsNCT06297369
What this trial is testing

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Who this might be right for
Cisplatin Adverse ReactionCisplatin NephrotoxicityCisplatin Induced Peripheral Neuropathy+2 more
Ain Shams University 60
Not applicableUnknownNCT05851222
What this trial is testing

A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP)

Who this might be right for
Acute Kidney InjuryDrug UseDrug Interaction+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 4,200
Not applicableUnknownNCT05899751
What this trial is testing

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

Who this might be right for
Acute Kidney InjuryDrug Toxicity
Protherics Medicines Development Limited 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT03480971
What this trial is testing

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who this might be right for
MucositisNephrotoxicityOtotoxicity
Matrix Biomed, Inc. 120
Load More Results